Online public engagement is in line with the government's aspiration to support the principles of transparency and equality for the implementation of a law.
Therefore, this page is available for public consultation and will present new proposals or amendments to the draft law (including laws, policies, regulations, etc.). The draft will appear on this page for a period of 14 working days.
The public is encouraged to provide comments and views on the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia during this period.
Feedback/Comment Period : 16/04/2019 - 15/05/2019
Slides
| No | Document | Download |
| 1. | Public Consultation On Implementation Of Bioequivalence (BE) Study Requirements For New Drug Products Containing Scheduled Poison | Download |
Feedback/Comment Form
| No | Document | Download |
| 1. | Comment Form | Download |
Please email the filled table to Dr Yvonne Khoo ( This email address is being protected from spambots. You need JavaScript enabled to view it. ) by 15 May 2019.
Thank you for taking time to assist in our efforts towards process improvement.
